EUVIMEDEUVIMED entdecken
Crossref

Screening Results for Diabetic Retinopathy in Germany in a Real-world Cohort in a Metropolitan Diabetes Care Center

Bernardo Mertes, Nadine Kuniss, Michael Piorkowski, Linus Paul Mertes, Hans-Peter Hammes

Experimental and Clinical Endocrinology & Diabetes · 01.04.2023 · 131 (04) · 182-186

DOI: 10.1055/a-2002-5116 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental and Clinical Endocrinology & Diabetes, erschienen am 01.04.2023. Verfasst von Bernardo Mertes und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Cardioangiology Bethanien, AGAPLESION Hospital Bethanien, Department for Diabetology. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Retinal screening is mandatory to prevent vision loss and blindness due to diabetic retinopathy (DR). The aim of the study was to determine retinopathy screening rates and potential barriers in a German metropolitan diabetes care center.

Methods

Between May and October 2019, 265 patients with diabetes mellitus (95% type 2 diabetes; age 62±13.2 years; diabetes duration 11.1±8.5 years, HbA1c 7.4±1.0%) were referred to an ophthalmologist (referral form with order “Fundoscopy in diabetes mellitus, findings requested,” completed documentation form “General practitioner’s/diabetologist’s report to the ophthalmologist” and prepared documentation form “Ophthalmologist’s report”). A structured interview was used to assess the level of compliance with the guidelines and to identify potential barriers to retinopathy screening in a real-world setting, including the quantification of extra payments.

Results

All patients were interviewed at 7.9±2.5 months after the referral for retinopathy screening had been issued. According to patient reporting, fundoscopy was performed in 191 (75%) patients. Ophthalmological reports were obtained from 119/191 (62%) patients (46% of the entire cohort). 10/119 (8%) patients had been previously diagnosed with DR and 6/119 (5%) with new-onset DR. In 158/191 (83%) of patients, the referral had been accepted by the ophthalmology practice, of which 25,1% made a co-payment of 36.2±37.6 €.

Discussion

Despite a high screening performance in a real-world setting, complete screening in compliance with German guidelines, including written reporting, was found in less than half of the cohort. The prevalence and incidence of DR are high. Even when referred according to the regulations, one-quarter of patients made a co-payment. Efficient solutions to current barriers can emerge with mutual time-saving information prior to examination and feedback about the implementation of findings into treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic RetinopathyDiabetes Mellitus, Type 2HumansMiddle AgedAgedMass ScreeningReferral and ConsultationGermany

Autor:innen und Institutionen

  • Centre for Cardioangiology Bethanien, AGAPLESION Hospital Bethanien, Department for Diabetology.
  • Jena University Hospital, Department of Internal Medicine III.
  • Universitätsmedizin Mannheim, University of Heidelberg, 5th Medical Department.

Zitieren

APA

Mertes, B., Kuniss, N., Piorkowski, M., Mertes, L. P., & Hammes, H. P. (2023). Screening Results for Diabetic Retinopathy in Germany in a Real-world Cohort in a Metropolitan Diabetes Care Center. Experimental and Clinical Endocrinology & Diabetes, 131(04), 182-186. https://doi.org/10.1055/a-2002-5116

Vancouver

Mertes B, Kuniss N, Piorkowski M, Mertes LP, Hammes HP. Screening Results for Diabetic Retinopathy in Germany in a Real-world Cohort in a Metropolitan Diabetes Care Center. Experimental and Clinical Endocrinology & Diabetes. 2023;131(04):182-186. doi:10.1055/a-2002-5116

BibTeX
@article{Mertes2023,
  author = {Mertes, Bernardo and Kuniss, Nadine and Piorkowski, Michael and Mertes, Linus Paul and Hammes, Hans-Peter},
  title = {Screening Results for Diabetic Retinopathy in Germany in a Real-world Cohort in a Metropolitan Diabetes Care Center},
  journal = {Experimental and Clinical Endocrinology & Diabetes},
  year = {2023},
  volume = {131},
  number = {04},
  pages = {182--186},
  doi = {10.1055/a-2002-5116}
}
Kostenlos starten →